Surgical Polypropylene Mesh Market Analysis
The Surgical Polypropylene Mesh Market is expected to register a CAGR of 4.4% during the forecast period.
Several factors are expected to drive the market's expansion, including the increasing number of surgeries, rising healthcare expenditure, and technological advancements in surgical polypropylene mesh.
In recent years, a rise has been observed in the number of surgeries, which is expected to increase the demand for surgical polypropylene mesh, propelling market growth. For instance, according to a report published by UpToDate in April 2022, the lifetime prevalence of groin hernias was estimated to be 27% to 43% in males and 3% to 6% in females in 2022. Groin hernias are the most common surgical condition encountered by primary care clinicians, with 1.6 million diagnosed annually and 500,000 undergoing operative repairs in the United States.
Additionally, the same source reported that 20 million groin hernia repairs are performed annually worldwide, with inguinal hernia repair being the most common of all abdominal wall hernia operations. Therefore, the increasing prevalence of hernia cases and related complications is expected to accelerate the market's growth.
A report published by the PubMed Journal in April 2022 reported a prevalence of 1.7% for abdominal wall hernia across all ages. These hernias accounted for 15% to 18% of all surgical procedures, and more than 20 million hernias were operated on worldwide annually. This increasing number of hernia surgeries is expected to promote the high usage of surgical polypropylene mesh and market growth during the forecast period.
Major players in the market are also working on novel growth strategies, such as product approvals and launches, to cater to the rising demand for surgical polypropylene mesh. For instance, in June 2023, the FDA approved Advanced Medical Solutions Limited for LIQUIFIX Hernia Mesh Fixation (HMF) Devices, which include the FIX8 Laparoscopic HMF Device and the Precision Open HMF Device. These innovative devices feature an adhesive preloaded into a single-use, handheld applicator. They are designed to secure prosthetic polypropylene or polyester mesh during laparoscopic and open surgical femoral and inguinal hernias repair.
In conclusion, owing to the rise in hernia cases and the rising product approvals, the market studied is anticipated to grow over the forecast period. However, the risks associated with using mesh are expected to restrain market growth during the forecast period.
Surgical Polypropylene Mesh Market Trends
Hernia Repair Segment is Expected to Register Considerable Growth Over the Forecast Period
Hernia repair surgery, also known as herniorrhaphy, involves the restoration of displaced tissues to their proper position. Hernioplasty is a type of hernia repair surgery involving sewing a mesh patch over the weakened tissue area. Robotic surgery has made it easier for surgeons to sew tissue and meshes inside the abdomen. As a result, the increase in hernia repair cases is expected to be a significant driver of segment growth over the forecast period.
Technological advancements in the hernia repair surgical polypropylene domain are expected to propel the segment's growth. For instance, according to a report published by the Materials Journal in November 2023, the advancements in hernia mesh design, particularly in the development of lightweight materials, improved attachment mechanisms, antimicrobial properties, and composite textiles, driving the growth of the surgical polypropylene mesh market by addressing the limitations of existing products and enhancing clinical outcomes. This surge in innovation, coupled with the promising results from recent clinical trials, is expected to significantly expand the market as these new and improved mesh solutions meet the growing demand for practical and durable hernia repair options.
Moreover, the advantages of polypropylene mesh during hernia repair surgery propel the segment's growth. For instance, according to an article published by the Universal Sutures in May 2023, the use of polypropylene mesh in hernia repair surgery drove market growth by significantly reducing the risk of hernia recurrence and improving patient outcomes, enhancing the overall value proposition for both healthcare providers and patients. Additionally, the mesh's ability to minimize surgical time and improve postoperative recovery increases its adoption among surgeons, further propelling market expansion due to its demonstrated clinical efficacy and cost-effectiveness.
In conclusion, due to the rise in hernia cases and the increase in research studies relating to the advantages of using polypropylene mesh in hernia repair, this segment is expected to witness significant growth in the market over the forecast period.
North America is Expected to Hold a Significant Share in the Surgical Polypropylene Mesh Market Over the Forecast Period
North America is expected to maintain a substantial global market share throughout the forecast period, primarily due to several factors. First, there has been a rise in diseases that require surgical interventions, leading to an increase in the use of surgical polypropylene mesh over traditional sutures. Second, significant technological advancements in surgical polypropylene mesh have further boosted its adoption in surgical procedures.
For instance, according to a report published by the BMC Women’s Health Journal in March 2024, in the United States, the prevalence of prolapse among women aged 18 to 83 is reported at 21.7%. This figure escalates to 27% and 30% for women aged 30 to 49 and 50 to 89, respectively. These statistics indicate a growing number of prolapse cases in the region and, in turn, an increase in demand for surgical polypropylene mesh for surgical procedures.
Furthermore, companies have established a robust direct channel collaboration with hospitals and clinics to serve the market effectively. In Canada, as per the article published in September 2022 in the Canadian Journal of Surgery, a study conducted in Eastern Ontario showed that the anterior open approach with a mesh patch is the most commonly used method in inguinal hernia repair. Moreover, investments in surgeries by the government and private firms in the region are expected to promote market growth. For example, Canada committed USD 2 billion in additional healthcare funding in March 2022 to clear backlogs and support hundreds of thousands of further surgeries.
Additionally, increased clinical studies demonstrating the advantages of surgical mesh in hernia surgeries are expected to fuel market growth. For instance, in November 2022, Cleveland Clinic sponsored a clinical trial to compare the quality of life one year postoperatively for patients undergoing incisional hernia repair with mesh versus suture repair using modern techniques. In this study, participants will undergo incisional hernia repair with prolene mesh in the retro rectus position with at least 4cm of overlap.
In conclusion, due to the rise in cases of hernia and increasing research studies related to polypropylene mesh, North America is expected to hold a significant market share over the forecast period.
Surgical Polypropylene Mesh Industry Overview
The global surgical polypropylene mesh market is characterized by moderate levels of competition and is comprised of several key players. Some of the major companies operating in the market include Pierson Surgical Ltd, Becton, Dickinson and Company, Bio-Rad, Johnson & Johnson, Medtronic, and Mölnlycke Health Care AB. These players hold a significant share of the market and compete on the basis of factors such as product quality, innovation, and pricing strategies.
Surgical Polypropylene Mesh Market Leaders
Becton, Dickinson and Company
Pierson Surgical Ltd
Medtronic plc
Johnson & Johnson
Mölnlycke Health Care AB
- *Disclaimer: Major Players sorted in no particular order
Surgical Polypropylene Mesh Market News
- March 2024: Durham-based Deep Blue Medical launched its T-Line Hernia Mesh, a surgical polypropylene mesh that helps prevent the recurrence of hernias after abdominal hernia repair surgery.
- March 2024: TELA Bio Inc. launched its LIQUIFIX FIX8 Laparoscopic and LIQUIFIX Precision Open Hernia Mesh Fixation Devices in the United States. LIQUIFIX FIX8 is indicated for minimally invasive femoral and inguinal hernia repairs, and LIQUIFIX Precision is indicated for open femoral and inguinal hernia repairs.